schalk
hawn
describ
unknown
respiratori
diseas
neonat
chick
us
consider
loss
observ
diseas
highli
contagi
name
diseas
infecti
bronchiti
young
chick
beach
schalm
show
diseas
caus
specif
viru
known
infecti
bronchiti
viru
ibv
member
coronaviru
genu
within
coronavirida
first
time
beaudett
hudson
grew
viru
chorioallanto
membran
embryon
chicken
egg
past
year
mani
new
infecti
bronchiti
ib
serotyp
variant
describ
jungherr
et
al
anonym
although
massachusett
serotyp
one
diagnos
netherland
hoekstra
rispen
serotyp
may
aris
either
result
spontan
mutat
recombin
kuster
et
al
cavanagh
et
al
wang
et
al
jia
et
al
crossprotect
differ
serotyp
variabl
poor
cavanagh
therefor
choic
vaccin
strain
care
consid
care
correct
diagnosi
de
wit
also
need
ibv
identif
outbreak
ib
still
occur
vaccin
flock
viru
strain
isol
outbreak
frequent
differ
serotyp
vaccin
strain
appli
bijlenga
diagnos
ib
first
time
netherland
mean
viru
isol
experiment
infect
chicken
serum
neutral
sn
test
viru
isol
use
prepar
vaccin
serial
passag
embryon
chicken
egg
passag
level
bijlenga
vaccin
name
ib
vaccin
strain
h
stand
initi
letter
name
huyben
owner
broiler
farm
provinc
brabant
southern
part
netherland
viru
isol
letter
h
often
use
mistakenli
rosenberg
et
al
winterfield
et
al
winterfield
et
al
owen
et
al
abbrevi
holland
public
rectifi
mistak
concentr
describ
origin
h
strain
vaccin
isol
adapt
embryon
egg
well
origin
experiment
field
vaccin
perform
almost
year
ago
inform
h
strain
publish
thesi
german
bijlenga
work
wide
recogn
reason
public
clarifi
intern
level
continu
confus
anonym
surround
origin
develop
vaccin
still
use
worldwid
review
also
discuss
crossprotect
studi
use
h
vaccin
strain
touch
use
ib
vaccin
problem
relat
occurr
multipl
serotyp
subtyp
ib
viru
also
consid
final
look
futur
discuss
potenti
attribut
ibv
vaccin
futur
june
broiler
receiv
state
serum
institut
rotterdam
netherland
huyben
farm
north
brabant
broiler
show
respiratori
problem
similar
observ
farm
sinc
paralysi
observ
faec
normal
mortal
flock
morbid
rang
haemagglutin
inhibit
hi
test
newcastl
diseas
nd
perform
serum
sampl
neg
viru
isol
attempt
use
brain
tissu
two
broiler
view
clinic
sign
decid
tri
isol
caus
agent
presum
ib
viru
tracheal
mucu
two
broiler
show
respiratori
problem
suspend
steril
physiolog
salin
contain
antibiot
min
room
temperatur
supernat
inocul
allanto
caviti
five
embryon
chicken
egg
ml
per
egg
day
incub
embryo
still
aliv
allanto
fluid
af
harvest
embryon
abnorm
observ
af
inocul
way
anoth
five
embryon
egg
blind
passag
second
egg
passag
two
embryo
die
day
incub
af
two
egg
harvest
next
passag
perform
materi
passag
carri
use
af
embryo
die
except
first
blind
passag
tabl
third
passag
one
embryo
die
day
inocul
amnion
thicken
adher
close
embryo
dwarf
embryo
weigh
g
age
normal
embryo
weigh
approxim
g
curl
spheric
form
deform
feet
head
bijlenga
embryon
chang
typic
ib
infect
provision
diagnosi
viru
caus
agent
problem
huyben
farm
continu
passag
viru
becam
adapt
embryon
egg
tabl
dwarf
effect
observ
passag
higher
passag
phenomenon
disappear
embryo
mortal
observ
passag
level
inocul
egg
die
within
h
inocul
decid
test
viru
potenti
vaccin
stock
viru
prepar
passag
level
suffici
perform
experiment
vaccin
studi
laboratori
field
condit
experi
broiler
chick
vaccin
mix
vaccin
drink
water
fifti
chick
vaccin
earli
passag
vaccin
second
group
chick
passag
third
group
chick
kept
nonvaccin
control
group
clinic
sign
observ
group
vaccin
passag
level
wherea
group
given
passag
two
chick
die
day
vaccin
respect
macroscop
lesion
respiratori
tract
chick
includ
tracheal
mucu
tracheiti
airsaccul
day
week
month
vaccin
blood
sampl
collect
vaccin
group
order
perform
sn
test
use
highli
eggadapt
beaudett
strain
ibv
passag
level
constant
serum
dilut
viru
method
bijlenga
group
show
high
ib
sn
titr
ie
neutral
indic
least
neg
titr
mark
differ
group
observ
serum
antibodi
titr
chick
vaccin
passag
remain
high
month
vaccin
sera
chick
vaccin
passag
level
examin
week
week
month
vaccin
viru
consid
virul
field
trial
perform
close
collabor
veterinari
servic
inspector
eastern
southern
western
part
netherland
bird
vaccin
via
drink
water
vaccin
viru
dose
median
embryo
infecti
dose
per
millilitr
care
taken
use
utensil
clean
disinfect
appli
also
exposur
water
contain
sunlight
ultraviolet
avoid
prevent
inactiv
vaccin
viru
four
poultri
farm
select
ib
previous
occur
chick
vaccin
follow
week
old
week
old
broiler
week
old
clinic
sign
observ
first
day
vaccin
day
vaccin
respiratori
problem
seen
three
poultri
farm
chick
vaccin
week
age
mortal
vari
broiler
vaccin
week
show
clinic
sign
blood
sampl
collect
week
month
vaccin
major
sera
collect
week
show
high
sn
titr
sera
collect
month
vaccin
still
high
titr
bijlenga
anoth
poultri
farm
southern
netherland
nd
ib
problem
observ
combin
vaccin
experi
use
passag
level
h
strain
hitchner
strain
nd
carri
via
drink
water
total
chick
day
age
vaccin
nd
ib
ten
blood
sampl
collect
vaccin
sera
show
high
ib
sn
titr
probabl
due
matern
antibodi
day
vaccin
slight
respiratori
sign
observ
probabl
due
ib
vaccin
mortal
observ
less
week
vaccin
high
ib
sn
titr
observ
nd
hi
titr
encount
vaccin
day
combin
vaccin
nine
sera
show
nd
hi
titr
order
examin
influenc
passag
vaccin
strain
h
egg
product
two
poultri
farm
select
western
netherland
area
free
ib
small
number
blood
sampl
differ
age
group
collect
serum
sampl
examin
sn
test
vaccin
neg
thu
confirm
ib
infect
occur
region
egg
product
record
day
vaccin
order
observ
possibl
subsequ
declin
product
chicken
month
age
month
age
month
month
age
vaccin
via
drink
water
final
dose
vaccin
median
embryo
infecti
dose
per
bird
hen
yet
start
lay
thu
includ
trial
clinic
sign
observ
vaccin
vaccin
procedur
advers
influenc
egg
product
egg
shell
qualiti
six
week
vaccin
high
sn
titr
observ
indic
immunolog
respons
vaccin
time
consid
passag
ib
vaccin
strain
h
virul
chick
confirm
four
year
later
hoekstra
rispen
therefor
egg
passag
necessari
attenu
viru
use
vaccin
chick
decid
obtain
passag
level
prove
greatli
reduc
virul
hoekstra
rispen
viru
known
vaccin
lower
passag
passag
vaccin
higher
virul
known
vaccin
strain
vaccin
viru
use
success
primari
vaccin
broiler
worldwid
almost
year
also
initi
vaccin
breeder
futur
layer
field
strain
massachusett
serotyp
believ
continu
caus
diseas
mani
area
world
li
yang
meuleman
et
al
farsang
et
al
cavanagh
naqi
togeth
evid
broad
protect
h
strain
vaccin
see
later
probabl
account
continu
success
except
australia
countri
develop
uniqu
lineag
ib
serotyp
sapat
et
al
h
vaccin
strain
licens
liveattenu
ib
vaccin
h
vaccin
strain
must
replic
respiratori
tract
stimul
protect
immun
follow
therefor
damag
epitheli
layer
respiratori
tract
occur
fine
balanc
must
achiev
strain
overattenu
unabl
replic
suffici
stimul
immun
one
insuffici
attenu
seriou
damag
may
occur
viru
meet
criteria
well
ideal
suit
use
young
suscept
chick
vaccin
less
attenu
suitabl
use
older
chicken
alreadi
protect
immun
result
earlier
applic
milder
attenu
vaccin
perhap
ib
field
exposur
also
despit
proven
safeti
vaccin
young
suscept
chick
must
rememb
live
ibv
vaccin
increas
suscept
colibacillosi
high
escherichia
coli
pressur
smith
et
al
matthij
et
al
function
liveattenu
vaccin
stimul
local
system
cellmedi
immun
cmi
viru
immun
respons
ibv
review
dhinakar
raj
jone
cavanagh
use
either
h
strain
gillett
toro
fernandez
strain
hawk
et
al
import
local
immun
respiratori
tract
first
line
defenc
ib
challeng
demonstr
furthermor
davelaar
kouwenhoven
use
vaccin
strain
demonstr
import
harderian
gland
develop
immun
induc
ib
vaccin
find
confirm
toro
et
al
histolog
studi
demonstr
increas
plasma
cell
number
enlarg
lymphoid
foci
follow
eyedrop
administr
vaccin
therefor
essenti
local
immun
stimul
care
applic
live
attenu
ib
vaccin
addit
induct
high
persist
level
system
immun
necessari
provid
lifelong
protect
ib
challeng
although
role
cmi
protect
ib
challeng
less
well
studi
aspect
ibinduc
immun
evid
cmi
respons
occur
follow
vaccin
h
strain
timm
bracewel
furthermor
suggest
cmi
respons
vaccin
may
crossreact
dhinakar
raj
jone
correct
care
applic
ib
vaccin
therefor
essenti
optim
stimul
type
protect
immun
immun
chicken
ibv
follow
initi
live
viru
vaccin
natur
infect
gener
solid
longlast
upon
challeng
strain
homolog
serotyp
cours
magnitud
durat
respons
vaccin
depend
mani
factor
includ
age
chick
level
matern
immun
immunogen
vaccin
method
vaccin
applic
virul
field
strain
challeng
interv
vaccin
challeng
immunocompet
host
chicken
vaccin
optim
condit
may
immun
last
mani
month
broiler
may
lifelong
abil
vaccin
chicken
resist
challeng
strain
heterolog
serotyp
howev
much
doubt
ibv
serotyp
highli
unrel
one
anoth
gener
crossprotect
well
issu
primari
reason
ib
difficult
control
field
condit
flock
like
becom
infect
heterolog
field
strain
commonli
refer
variant
h
strain
massachusett
serotyp
ib
vaccin
shown
rare
abil
crossprotect
heterolog
serotyp
thu
make
potenti
effect
control
broader
rang
serotyp
research
laboratori
evalu
lower
eggpassag
strain
vaccin
heterolog
strain
found
us
winterfield
fadli
report
vaccin
immun
well
provid
protect
challeng
connecticut
jmk
iowa
iowa
florida
holt
gray
serotyp
rosenberg
et
al
found
crossprotect
well
challeng
us
serotyp
connecticut
jmk
florida
holt
much
lesser
degre
arkansa
gray
main
protect
studi
assess
week
vaccin
challeng
chick
via
respiratori
tract
perform
viru
recoveri
attempt
trachea
day
later
higher
eggpassag
h
strain
vaccin
also
evalu
crossprotect
abil
winterfield
fadli
found
egg
passag
vaccin
increas
attenu
crossprotect
wane
although
complet
highli
attenu
vaccin
protect
averag
well
compar
parent
strain
one
egg
pass
remov
vaccin
vaccin
found
induc
protect
respiratori
tract
heterolog
challeng
strain
belgian
french
french
serotyp
cook
et
al
although
protect
improv
chick
revaccin
vaccin
heterolog
serotyp
parson
et
al
work
protect
respiratori
tract
assess
quantifi
damag
caus
epithelium
trachea
follow
challeng
attempt
mimic
situat
commonli
seen
field
cook
et
al
vaccin
chick
vaccin
challeng
mix
infect
compris
pool
e
coli
isol
heterolog
ibv
strain
massachusett
serotyp
good
crossprotect
found
follow
challeng
sever
heterolog
ibv
strain
examin
given
conjunct
e
coli
challeng
good
crossprotect
observ
includ
holt
iowa
usa
australian
netherland
sever
uk
isol
research
use
intermedi
eggpassag
level
h
strain
vaccin
found
could
use
safe
commerci
type
broiler
without
seriou
respiratori
side
effect
retent
crossprotect
characterist
egg
passag
h
strain
use
primari
vaccin
broiler
initi
crossprotect
heterolog
serotyp
challeng
winterfield
et
al
booster
vaccin
intermedi
level
h
vaccin
found
increas
crossprotect
level
winterfield
et
al
enhanc
crossprotect
variant
ib
strain
observ
intermedi
h
strain
vaccin
given
combin
arkansa
dpi
strain
gelb
et
al
present
time
although
use
oil
adjuv
inactiv
ib
vaccin
booster
vaccin
breeder
layer
pullet
flock
becom
common
practic
mani
part
world
strain
still
use
purpos
area
howev
commonli
use
vaccin
young
broiler
pullet
potenti
virul
side
effect
use
primari
vaccin
winterfield
et
al
hand
intermedi
passag
level
h
strain
safe
use
vaccin
broader
spectrum
crossprotect
need
variant
ibv
challeng
gelb
et
al
field
protect
flock
level
greater
interest
protect
bird
level
import
know
vaccin
prevent
transmiss
ib
challeng
viru
infect
bird
flock
howev
vaccin
challeng
trial
efficaci
ib
vaccin
usual
express
percentag
vaccin
bird
protect
challeng
therefor
order
obtain
relev
inform
differ
approach
vaccin
efficaci
determin
investig
de
wit
et
al
worker
perform
studi
flock
immun
vaccin
challeng
order
determin
whether
vaccin
reduc
viru
transmiss
test
whether
ibv
transmiss
among
vaccin
chicken
significantli
reduc
compar
among
unvaccin
chicken
two
vaccin
two
unvaccin
group
specif
pathogen
free
chicken
standard
measur
viru
transmiss
reproduct
ratio
determin
reproduct
ratio
defin
averag
number
new
infect
caus
one
typic
infecti
individu
entir
infecti
period
found
singl
eyedrop
vaccin
reduc
transmiss
challeng
viru
among
vaccin
chicken
significantli
compar
transmiss
among
unvaccin
chicken
ibv
vaccin
far
test
way
control
ib
arguabl
challeng
poultri
infecti
diseas
new
variant
serotyp
emerg
introduc
poultri
unpredict
manner
mani
countri
nativ
indigen
serotyp
begin
discov
character
therefor
identif
preval
serotyp
need
develop
effect
vaccin
control
diseas
discuss
earlier
live
vaccin
provid
excel
often
steril
immun
homolog
serotyp
challeng
gener
variant
heterolog
serotyp
howev
live
vaccin
strain
strain
may
also
provid
crossprotect
heterolog
serotyp
live
attenu
vaccin
costeffect
poultri
industri
especi
broiler
product
although
two
drawback
vaccin
worthi
mention
live
vaccin
produc
vari
degre
patholog
may
make
unsuit
use
flock
depend
variou
factor
age
matern
activ
immun
statu
presenc
concurr
infect
second
difficulti
associ
import
correct
applic
live
ib
vaccin
probabl
underestim
vaccin
instabl
revers
virul
seriou
concern
vaccin
accident
purpos
dilut
clearli
improv
live
vaccin
stabil
safeti
need
futur
inactiv
ib
vaccin
use
booster
vaccin
benefici
egglay
perform
breeder
layer
hen
howev
inactiv
ib
vaccin
effect
use
booster
flock
follow
prime
vaccin
liveattenu
ib
vaccin
immun
inactiv
vaccin
reduc
gener
elimin
viral
shed
follow
challeng
virul
strain
homolog
serotyp
ladman
et
al
inactiv
ib
vaccin
gener
crossprotect
well
heterolog
challeng
although
given
prior
week
age
may
protect
pullet
place
layer
farm
complex
variant
serotyp
known
exist
ladman
et
al
expens
cost
product
need
administr
inject
inactiv
vaccin
safe
replic
bird
improv
efficaci
kill
ib
vaccin
primari
immunogen
appli
respiratori
tract
would
benefit
induc
local
respiratori
immun
without
drawback
associ
use
live
vaccin
new
technolog
provid
opportun
vaccin
improv
use
live
attenu
ib
vaccin
ovo
wakenel
sharma
wakenel
et
al
investig
subsequ
hatchabl
shown
poor
chew
et
al
probabl
inher
abil
ibv
even
attenu
strain
replic
damag
produc
patholog
chicken
embryo
immun
technolog
includ
use
transgenicderiv
ibv
protein
song
et
al
zhou
et
al
dna
vaccin
seo
et
al
kapczynski
et
al
homolog
ibv
vector
recombin
casai
et
al
dove
et
al
hodgson
et
al
heterolog
virusvector
vaccin
yu
et
al
wang
et
al
johnson
et
al
vaccin
deliveri
continu
issu
advanc
field
avian
immunolog
may
well
prove
benefici
howev
much
technolog
infanc
promis
efficaci
method
deliveri
cost
import
consider
determin
actual
util
poultri
industri
seem
like
mani
year
novel
ib
vaccin
commerci
avail
therefor
forese
futur
necessari
continu
optim
use
current
avail
vaccin
live
attenu
ib
vaccin
massachusett
serotyp
well
serotyp
came
promin
develop
year
howev
h
vaccin
strain
particularli
vaccin
intermedi
eggpassag
h
vaccin
stood
test
time
still
use
worldwid
year
initi
develop
indic
valu
efficaci
h
vaccin
strain
challeng
homolog
heterolog
serotyp
furthermor
vaccin
found
conform
rigor
safeti
standard
requir
avian
vaccin
final
despit
advanc
molecular
biolog
novel
approach
consid
develop
avian
anim
vaccin
appar
simpl
method
use
attenu
ibv
name
serial
passag
embryon
egg
continu
effect
way
produc
safe
inexpens
vaccin
h
strain
ib
well
mani
variant
gelb
cloud
jackwood
et
al
